Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
seattle top stories
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
medicare
messenger rna
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
What
million
3
×
therapeutics
cancer
ipo
new
sciences
adding
allogene
bets
bio
biotechs
boost
club
companies
continued
crispr
crop
diversity
drug
exceeded
expensive
far
firms
gilead
group
haul
hot
immunotherapy
investors
joined
juno
latest
life
met
momentum
nasdaq
nearly
neon
offerings
paying
Language
Current search:
million
×
" san francisco blog main "
×
" seattle top stories "
×
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M